Niraparib and Temozolomide in Patients Glioblastoma
Clinical trial NCT06258018 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06258018
- Sponsor
- Armando Santoro, MD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2026-12-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.